Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2006 Nov 14:5:108.
doi: 10.1186/1475-2875-5-108.

Combined chloroquine, sulfadoxine/pyrimethamine and primaquine against Plasmodium falciparum in Central Java, Indonesia

Affiliations
Randomized Controlled Trial

Combined chloroquine, sulfadoxine/pyrimethamine and primaquine against Plasmodium falciparum in Central Java, Indonesia

Edith R Lederman et al. Malar J. .

Abstract

Background: Chloroquine (CQ) or sulfadoxine-pyrimethamine (SP) monotherapy for Plasmodium falciparum often leads to therapeutic failure in Indonesia. Combining CQ with other drugs, like SP, may provide an affordable, available and effective option where artemisinin-combined therapies (ACT) are not licensed or are unavailable.

Methods: This study compared CQ (n = 29 subjects) versus CQ + SP (with or without primaquine; n = 88) for clinical and parasitological cure of uncomplicated falciparum malaria in the Menoreh Hills region of southern Central Java, Indonesia. Gametocyte clearance rates were measured with (n = 56 subjects) and without (n = 61) a single 45 mg dose of primaquine (PQ).

Results: After 28 days, 58% of subjects receiving CQ had cleared parasitaemia and remained aparasitaemic, compared to 94% receiving CQ combined with SP (p < 0.001). Msp-2 genotyping permitted reinfection-adjusted cure rates for CQ and CQ combined with SP, 70% and 99%, respectively (p = 0.0006).

Conclusion: Primaquine exerted no apparent affect on cure of asexual stage parasitaemia, but clearly accelerated clearance of gametocytes. CQ combined with SP was safe and well-tolerated with superior efficacy over CQ for P. falciparum parasitaemia in this study.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The recruitment, enrollment and randomization process for this study evaluating four treatment regimens for uncomplicated P. falciparum in residents of Purworejo District, Central Java, Indonesia.
Figure 2
Figure 2
(A) Asexual parasite clearance time in 117 subjects with falciparum malaria after treatment with one of 4 different regimens. (B) Time of fever clearance in 38 subjects with fever at the time of study enrollment. CQ = chloroquine, SP = sulfadoxine/pyrimethamine, and PQ = primaquine on either day 0 (d0) or day 2(d2) of therapy.
Figure 3
Figure 3
Gametocyte rates in 117 subjects with falciparum malaria after treatment with one of 4 different regimens. CQ = chloroquine, SP = sulfadoxine/pyrimethamine, and PQ = primaquine on either day 0 (d0) or day 2(d2) of therapy.

References

    1. White NJ. Preventing antimalarial drug resistance through combinations. Drug Resist Updat. 1998;1:3–9. doi: 10.1016/S1368-7646(98)80208-2. - DOI - PubMed
    1. Gogtay NJ, Desai S, Kadam VS, Kamtekar KD, Dalvi SS, Kshirsagar NA. A randomized, parallel-group study in Mumbai (Bombay), comparing chloroquine with chloroquine plus sulfadoxine-pyrimethamine in the treatment of adults with acute, uncomplicated, Plasmodium falciparum malaria. Ann Trop Med Parasitol. 2000;94:309–312. doi: 10.1080/00034980050034545. - DOI - PubMed
    1. Jayatilaka KDP, Taviri J, Kemiki A, Hwaihwanje I, Bulungol P. Therapeutic efficacy of chloroquine or amodiaquine in combination with sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Papua New Guinea. PNG Med J. 2003;46:125–134. - PubMed
    1. Maguire JD, Lacy MD, Sururi , Sismadi P, Krisin , Wiady I, Laksana B, Bangs MJ, Masbar S, Susanti I, Basuki W, Barcus MJ, Marwoto H, Edstein MD, Tjokrosonto S, Baird JK. Chloroquine or sulfadoxine-pyrimethamine for the treatment of uncomplicated, Plasmodium falciparum during an epidemic in Central Java, Indonesia. Ann Trop Med Parasitol. 2002;96:655–668. doi: 10.1179/000349802125002310. - DOI - PubMed
    1. Sumawinata IW, Bernadeta , Leksana B, Sutamihardja A, Purnomo , Subianto B, Sekartuti , Fryauff DJ, Baird JK. very high risk of therapeutic failure with chloroquine for uncomplicated Plasmodium falciparum and P. vivax malaria in Indonesian Papua. Am J Trop Med Hyg. 2003;68:416–420. - PubMed

Publication types

MeSH terms